New therapeutic concepts in prostate cancer.
Hamdy
F C
FC
Section of Urology, Division of Clinical Sciences, University of Sheffield, Sheffield, UK. F.C.Hamdy@sheffield.ac.uk
Thomas
B G
BG
D000726:Androgen Antagonists / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D004164:Diphosphonates / Q000627:therapeutic use; D016232:Endothelins / Q000502:physiology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000517:prevention & control / Q000628:therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism
D000726:Androgen Antagonists; D004164:Diphosphonates; D016232:Endothelins; D011505:Protein-Tyrosine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases